| DFI | Disease-free interval |
| ECOG | Eastern Cooperative Oncology Group performance status |
| ENETS | European Neuroendocrine Tumor Society |
| MDT | Multidisciplinary tumor board |
| MEN | Multiple endocrine neoplasia |
| NEC | Neuroendocrine carcinoma |
| OS | Overall survival |
| PRRT | Peptide receptor radionuclide therapy |
| RFA | Radiofrequency ablation |
| SIRT | Selective internal radiation therapy |
| SSAs | Somatostatin analogs |
| SSTR | Somatostatin receptor |
| TAE | Transarterial embolization |
| VHL | Von Hippel–Lindau syndrome |